News

CRO/SPONSOR : The Nuances of Medical Device Trials A Triggered Approach to Site Monitoring INFORMATION TECHNOLOGY : Automating the Phase I Trial Also in this issue : FDA Addresses Concerns Over Foreign Studies, The Cost Factor in EU Drug Authorization, Baseball?s Ties to Comparative Effectiveness Research, Key Updates to the Form FDA 1572

i_65-682209-1408628608853.jpg

How to make the leap beyond paper and EDC to create an automated clinical environment that thrives.

i1-682212-1408628599639.jpg

The design and completeness of the protocol and early and open communication with research center personnel are factors that most influence investigative site willingness to participate in a clinical study.